Skip to main content
. 2024 Mar 19;10(6):e28163. doi: 10.1016/j.heliyon.2024.e28163

Table 1.

Demographic and clinical characteristics of 62 volunteers.

Characteristic Data Min-Max
Age (years) 32.387 ± 5.320 22–43
Advanced (>35) 21 (33.87) 36–43
Normal (≤35) 41 (66.13) 28–31
PH
Abnormal 11 (17.74) /
Normal 51 (82.26) /
Hb (g/L) 115.016 ± 11.076 82.000–137.000
Abnormal 19 (30.65) 82.000–109.000
Normal 43 (69.35) 110.000–137.000
WBC (*10⁹/L) 8.897 ± 1.760 5.170–12.300
Platelet Count (*10⁹/L) 230.339 ± 48.428 125.000–366.000
Abnormal 5 (8.06) 301.000–366.000
Normal 57 (91.94) 125.000–299.000
Fibrinogen (mg/dL) 3.992 ± 0.620 1.870–5.600
Abnormal 3(4.84) 1.870, 5.570–5.600
Normal 59(95.16) 2.930–4.960
PT (S) 10.400 (9.900, 10.900) 9.300–14.100
Abnormal 6 (9.68) 9.300–9.600, 14.100
Normal 56 (90.32) 9.700–13.400
APTT (S) 28.050 (26.575, 29.575) 18.900–35.800
Abnormal 1 (1.61) 18.900
Normal 61 (98.39) 25.200–35.800
B-scan
Abnormal 9 (14.52) /
Normal 53 (85.48) /
GAA (D) 146.000 (140.000,154.250) 132.000–230.000
Chr
Abnormal 9 (14.52) /
Normal 53 (85.48) /
GAD (D) 272.463 ± 10.234 232.000–289.000
PO
Normal 47 (75.81) /
Induction 6 (9.68) /
PTB 3 (4.84) /
Complications 4 (6.45) /
Lost to follow-up 2 (3.22) /
FS
Male 31(57.41) /
Female 23 (42.59) /
BW (g) 3315.926 ± 505.444 2250.000–4570.000
Neonatal death
No death 53
Lost to follow-up 1

Categorical variables were presented as n (%). Normally distributed continuous variables were depicted by Mean ± SD, and nonnormally distributed continuous variables were represented as Q2 (Q1, Q3). Q1: First quartile; Q2: Second quartile; Q3: Third quartile. PH, pregnancy history; WBC, white blood cell count; Hb, haemoglobin; PLT, platelet count; FIB: Fibrinogen, PT, prothrombin time; APTT, activated partial thromboplastin time; B-scan, B-scan ultrasonography; GAA, gestational age at amniocentesis; Chr, chromosome structure; GAD, gestational age at delivery; PO, pregnancy outcome; PTB, preterm birth; FS, foetal sex; BW, birth weight; D: Days, S, seconds.